Olympiad Research LP Invests $213,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

Olympiad Research LP acquired a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the fourth quarter, Holdings Channel.com reports. The fund acquired 823 shares of the biotechnology company’s stock, valued at approximately $213,000.

A number of other hedge funds also recently made changes to their positions in AXON. BKM Wealth Management LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter worth about $32,000. Key Financial Inc boosted its holdings in shares of Axon Enterprise by 367.6% during the fourth quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock worth $41,000 after purchasing an additional 125 shares during the period. Lindbrook Capital LLC boosted its holdings in shares of Axon Enterprise by 43.3% during the fourth quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company’s stock worth $44,000 after purchasing an additional 52 shares during the period. Rakuten Securities Inc. purchased a new stake in shares of Axon Enterprise during the fourth quarter worth about $48,000. Finally, Principal Securities Inc. purchased a new stake in shares of Axon Enterprise during the fourth quarter worth about $49,000. 79.08% of the stock is owned by institutional investors.

Analyst Ratings Changes

AXON has been the subject of a number of research reports. Argus initiated coverage on shares of Axon Enterprise in a research note on Wednesday, March 13th. They issued a “buy” rating and a $380.00 price target for the company. Craig Hallum increased their price target on shares of Axon Enterprise from $325.00 to $370.00 and gave the stock a “buy” rating in a research note on Tuesday, May 7th. Morgan Stanley increased their price target on shares of Axon Enterprise from $285.00 to $310.00 and gave the stock an “equal weight” rating in a research note on Friday, April 26th. Robert W. Baird increased their price target on shares of Axon Enterprise from $260.00 to $300.00 and gave the stock an “outperform” rating in a research note on Thursday, February 22nd. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $400.00 target price on shares of Axon Enterprise in a research note on Tuesday, May 7th. Two equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $335.27.

Insider Activity at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 43,668 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $309.94, for a total value of $13,534,459.92. Following the sale, the insider now owns 189,719 shares in the company, valued at $58,801,506.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Jeri Williams sold 308 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $310.07, for a total value of $95,501.56. Following the sale, the director now owns 1,607 shares in the company, valued at $498,282.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jeffrey C. Kunins sold 43,668 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $309.94, for a total transaction of $13,534,459.92. Following the completion of the sale, the insider now owns 189,719 shares in the company, valued at approximately $58,801,506.86. The disclosure for this sale can be found here. Insiders sold 88,454 shares of company stock valued at $27,404,929 over the last 90 days. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Price Performance

Shares of AXON opened at $281.73 on Friday. The company has a market capitalization of $21.26 billion, a P/E ratio of 82.38 and a beta of 0.91. The company has a quick ratio of 2.55, a current ratio of 2.91 and a debt-to-equity ratio of 0.37. The firm has a 50 day moving average of $304.00 and a 200 day moving average of $275.85. Axon Enterprise, Inc. has a twelve month low of $175.37 and a twelve month high of $329.87.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.20. The company had revenue of $460.74 million during the quarter, compared to the consensus estimate of $441.57 million. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. The firm’s quarterly revenue was up 34.3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.51 earnings per share. As a group, equities research analysts anticipate that Axon Enterprise, Inc. will post 2.35 earnings per share for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.